Cove Biotechnologies LLC is categorized under Research and Development Laboratories in San Diego, CA and active since 2006.
Cove Biotechnologies LLC was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Henri C Van Der Heyde at the company’s single location by writing to 13247 Caminito Mediola, San Diego, California CA 92130 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cove Biotechnologies LLC |
| Contact Person: | Henri C Van Der Heyde |
| Address: | 13247 Caminito Mediola, San Diego, California 92130 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Cove Biotechnologies LLC was started in 2006 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Henri C Van Der Heyde for inquiries that concern Cove Biotechnologies LLC by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Cove Biotechnologies LLC can be found at the coordinates as well as the street address 13247 Caminito Mediola in San Diego, California 92130.
For its online presence, you may visit Cove Biotechnologies LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.